CNBC Squawk Alley April 6, 2016
Morning saying they will go their separate ways. This after treasury decided to change the rules midstream. At least something of a surprise to the companies themselves. The three year look back that was introduced by the new regulations issued monday evening and made allergen a far Smaller Company and in doing the deal as a Smaller Company, pfizer would not be able to make itself a Foreign Company. And you dont want to do this any longer. Not that there werent other reasons for doing the deal but perhaps even bring that cash back to the u. S. But in a tax freemaner is one of the key reasons p...